Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Uğur Eskiocak(Children’s Institute), Sean J. Morrison(Howard Hughes Medical Institute), Vijayashree Ramesh(Children’s Institute), Zhiyu Zhao(Children’s Institute), Jennifer G. Gill(Southwestern Medical Center), Mark Shackleton(Australian Research Council), Stacy W. Yuan(Children’s Institute), Meng Wang(Chinese Academy of Sciences), Timothy M. Johnson(University of Michigan), Arthur E. Frankel(The University of Texas Southwestern Medical Center), Elsa Quintana(Revolution Medicines (United States)), Ralph J. DeBerardinis(Children's Medical Center), Travis Vandergriff(The University of Texas Southwestern Medical Center)
Cited by 69
Related Papers
Efficient tumour formation by single human melanoma cells
|Nature|2008|1.8k
Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation
|Nature|2003|1.3k
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
|Nature|2006|1.3k
Guidelines of care for the management of primary cutaneous melanoma
|Journal of the American Academy of Dermatology|2018|707
m6A RNA Methylation Is Regulated by MicroRNAs and Promotes Reprogramming to Pluripotency
|Cell stem cell|2015|553